Bioxytran Inc. Appoints Two Investment Bankers from Westbury Group to Its Advisory Board
13 sept. 2019 14h39 HE
|
Bioxytran Inc.
BOSTON, MASSACHUSETTS, Sept. 13, 2019 (GLOBE NEWSWIRE) -- BIOXYTRAN, INC. (OTC: BIXT), a developmental stage biotechnology company, focused on delivering a small molecule carrying oxygen to the...
Bioxytran Inc. to Attend Multiple Investor Conferences in September
30 août 2019 14h31 HE
|
Bioxytran Inc.
BOSTON, MASSACHUSETTS, Aug. 30, 2019 (GLOBE NEWSWIRE) -- BIOXYTRAN, INC. (OTC: BIXT), a developmental stage biotechnology company developing a pipeline of novel anti-necrosis drugs designed to treat...
Bioxytran Inc. Announces Appointment of Dr. Hana Chen-Walden to Scientific Advisory Board
08 août 2019 07h00 HE
|
Bioxytran Inc.
BOSTON, MASSACHUSETTS, Aug. 08, 2019 (GLOBE NEWSWIRE) -- BIOXYTRAN, INC. (OTC: BIXT), a developmental stage biotechnology company developing a pipeline of anti-necrosis drugs designed to treat...
Bioxytran Inc. Appoints Cynthia Ekberg Tsai to Company Advisory Board
01 août 2019 07h00 HE
|
Bioxytran Inc.
BOSTON, MASSACHUSETTS, Aug. 01, 2019 (GLOBE NEWSWIRE) -- BIOXYTRAN, INC. (OTC: BIXT), a developmental stage biotechnology company with a pipeline of anti-necrosis drugs designed to treat hypoxia by...
Bioxytran Inc. Bolsters Advisory Board with Addition of Veteran Financial Advisor Jonathan Barkman
26 juil. 2019 15h52 HE
|
Bioxytran Inc.
BOSTON, July 26, 2019 (GLOBE NEWSWIRE) -- BIOXYTRAN, INC. (OTC: BIXT), a developmental stage biotechnology company developing a pipeline of anti-necrosis drugs designed to treat hypoxia by...
Avise Analytics Initiates Coverage on Bioxytran Inc.
23 juil. 2019 07h00 HE
|
Bioxytran Inc.
BOSTON, MASSACHUSETTS, July 23, 2019 (GLOBE NEWSWIRE) -- BIOXYTRAN, INC. (OTC: BIXT), a developmental stage biotechnology company developing a pipeline of anti-necrosis drugs designed to treat...
Bioxytran Inc. Invited to New York Venture Summit
09 juil. 2019 13h54 HE
|
Bioxytran Inc.
BOSTON, MASSACHUSETTS, July 09, 2019 (GLOBE NEWSWIRE) -- BIOXYTRAN, INC. (OTC: BIXT), a developmental stage biotechnology company developing a pipeline of novel anti-necrosis drugs designed to...
Bioxytran, Inc. Announces Public Company Executive Steve Aust to Join Advisory Board
12 juin 2019 07h00 HE
|
Bioxytran Inc.
BOSTON, MASSACHUSETTS, June 12, 2019 (GLOBE NEWSWIRE) -- BIOXYTRAN, INC. (OTC: BIXT), a developmental stage biotechnology company developing a pipeline of novel anti-necrosis drugs designed to...
BIOXYTRAN’S MDX VIEWER DEMONSTRATES EARLY WARNING SIGNS OF BRAIN HEALTH DURING CARDIOVASCULAR SURGERIES
06 juin 2019 07h00 HE
|
Bioxytran Inc.
MDX Viewer use during open heart surgery is an essential vital sign that could mitigate the risk of brain damage caused by prolonged oxygen deprivation during perioperative cardiovascular procedures...
Bioxytran Inc. Announces Availability of Updated Investor Presentation
29 mai 2019 10h22 HE
|
Bioxytran Inc.
BOSTON, MASSACHUSETTS, May 29, 2019 (GLOBE NEWSWIRE) -- BIOXYTRAN, INC. (OTC: BIXT), a developmental stage biotechnology company with a pipeline of anti-necrosis drugs designed to treat hypoxia by...